We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

65 hedge funds and large institutions have $47.9M invested in PDS Biotechnology in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 11

54% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 13

52% more call options, than puts

Call options by funds: $1.53M | Put options by funds: $1.01M

10% more funds holding

Funds holding: 59 → 65 (+6)

2.96% less ownership

Funds ownership: 23.76% → 20.8% (-3%)

52% less capital invested

Capital invested by funds: $101M → $47.9M (-$52.7M)

Holders
65
Holders Change
+6
Holders Change %
+10.17%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
25
Reduced
11
Closed
13
Calls
$1.53M
Puts
$1.01M
Net Calls
+$522K
Net Calls Change
-$1.01M

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$1.09M
2
Millennium Management
Millennium Management
New York
+$987K
3
Renaissance Technologies
Renaissance Technologies
New York
+$849K
4
First Manhattan
First Manhattan
New York
+$815K
5
SCA
Sassicaia Capital Advisers
New York
+$809K

Top Sellers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
-$5.01M
2
Invesco
Invesco
Georgia
-$4.91M
3
EI
EAM Investors
California
-$3.86M
4
EGI
EAM Global Investors
California
-$2.36M
5
WVP
Worth Venture Partners
New Jersey
-$1.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$8.22M +$400K +37,158 +4%
Two Sigma Advisers
2
Two Sigma Advisers
New York
$4.27M +$522K +48,500 +10%
Two Sigma Investments
3
Two Sigma Investments
New York
$3.91M +$1.09M +101,424 +27%
Renaissance Technologies
4
Renaissance Technologies
New York
$3.6M +$849K +78,900 +22%
BlackRock
5
BlackRock
New York
$3.5M +$24K +2,227 +0.5%
ACM
6
AIGH Capital Management
Maryland
$2.5M -$5.01M -465,526 -60%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$2.41M -$410K -38,078 -11%
First Manhattan
8
First Manhattan
New York
$2.2M +$815K +75,757 +39%
IWA
9
Inspirion Wealth Advisors
Illinois
$2M -$80K -7,437 -3%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$1.69M +$257K +23,873 +13%
SI
11
Sofinnova Investments
California
$1.16M – – –
Citadel Advisors
12
Citadel Advisors
Florida
$973K -$1.06M -98,965 -45%
FAM
13
Fred Alger Management
New York
$965K – – –
NLVP
14
New Leaf Venture Partners
New York
$950K – – –
Millennium Management
15
Millennium Management
New York
$743K +$987K +91,770 New
SCA
16
Sassicaia Capital Advisers
New York
$609K +$809K +75,200 New
State Street
17
State Street
Massachusetts
$587K +$102K +9,500 +15%
WVP
18
Worth Venture Partners
New Jersey
$574K -$1.15M -106,786 -60%
Marshall Wace
19
Marshall Wace
United Kingdom
$557K +$116K +10,756 +18%
CSS
20
Cubist Systematic Strategies
Connecticut
$524K -$74.8K -6,955 -10%
ACM
21
ACT Capital Management
Pennsylvania
$486K – – –
Commonwealth Equity Services
22
Commonwealth Equity Services
Massachusetts
$397K +$355K +32,955 +204%
TI
23
Trexquant Investment
Connecticut
$351K +$10.5K +980 +2%
Northern Trust
24
Northern Trust
Illinois
$339K +$26.5K +2,466 +6%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$314K – – –
1
2 3 4

PDSB Hedge Fund Activity: Q4 2021 in Review

65 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q4 2021, worth a combined $47.9M — down 52% from $101M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new PDSB positions and 13 closed out — a net gain of 7 holders — while 25 added to existing stakes and 11 trimmed.

The largest buyer was Two Sigma Investments, adding an estimated $1.09M. The largest seller was AIGH Capital Management, cutting an estimated $5.01M.

  • 65 institutional investors held PDS Biotechnology (PDSB) as of Q4 2021, up from 59 in Q3 2021.
  • Funds reported $47.9M of PDS Biotechnology stock for Q4 2021, down 52% quarter-over-quarter.
  • 20 funds opened new PDS Biotechnology positions in Q4 2021 and 13 closed out, a net change of +7 holders.
  • The largest PDS Biotechnology buyer in Q4 2021 was Two Sigma Investments, an estimated $1.09M added.
  • The largest PDS Biotechnology seller in Q4 2021 was AIGH Capital Management, an estimated $5.01M sold.

Based on aggregated 13F filings for Q4 2021.